Treatment of metastatic malignant melanoma with a two-part chemotherapy regimen consisting of velban-bleomycin-cisplatin (V-B-P) followed by dtic-dibromodulcitol (DTIC-DBD)

Stephen P Richman, T. Woodcock, M. Blumenreich

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - Dec 1 1982
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this